Physician profile
Midhat Patel
NPI 1508354499
$11,736.41
in general payments reported to CMS, 2019-2025
9 companies · $5,721 in 2025
The $5,721 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,171 · 2024: $4,844 · 2025: $5,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,435 · Travel and Lodging: $3,991 · Education: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,435.36 |
| Travel and Lodging | $3,991.36 |
| Education | $1,309.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,599.86 | 2023-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid, Aequalis Perform Reversed |
| Impactortho, INC. | $1,147.22 | 2023-2025 | |
| Arthrex, INC. | $955.13 | 2025 | |
| Shoulder Innovations, INC. | $512.29 | 2024-2025 | Inset System |
| Smith+Nephew, INC. | $130.17 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 7, Pico 14 |
| Catalyst Orthoscience | $127.79 | 2024 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System |
| Depuy Synthes Sales INC. | $124.99 | 2024 | Inhance |
| Zimmer Biomet Holdings, INC. | $123.32 | 2023 | Comprehensive Shoulder System |
| Rock Medical Orthopedics, INC. | $15.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Midhat Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.